Skip to content

    TEVA PHARMACEUTICAL INDUSTRIES LTD

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Trend
    EarningsRevenue
    $4.16B
    $4.33B
    $4.23B
    $3.89B
    $4.18B
    +0.3%
    $4.48B
    +3.4%
    $1.50B
    -64.5%
    $3.98B
    +2.3%
    Weakening
    Operating Profit
    -$5.00M
    -$51.00M
    -$29.00M
    $519.00M
    $455.00M
    $882.00M
    $301.00M
    $652.00M
    +25.6%
    Strengthening
    Net Profit
    -$846.00M
    -$437.00M
    -$217.00M
    $214.00M
    $282.00M
    $433.00M
    $481.00M
    $369.00M
    +72.4%
    Strengthening
    EPS
    $-0.75
    $-0.39
    $0.19
    $0.25
    $0.38
    $0.32
    +68.4%
    Strengthening
    Other Income
    -$241.00M
    -$272.00M
    -$218.00M
    -$225.00M
    -$252.00M
    -4.6%
    -$237.00M
    +12.9%
    -$220.00M
    -0.9%
    -$216.00M
    +4.0%
    Strengthening
    Interest
    Depreciation
    Profit before Tax
    -$246.00M
    -$324.00M
    -$247.00M
    $294.00M
    $203.00M
    $646.00M
    $80.00M
    $437.00M
    +48.6%
    Strengthening
    MarginsOPM
    -0.1%
    -1.2%
    -0.7%
    13.3%
    10.9%
    19.7%
    20.1%
    16.4%
    +22.7%
    Strengthening
    Tax
    -256.1%
    -21.3%
    -11.7%
    25.2%
    -38.4%
    +85.0%
    33.1%
    -487.5%
    -4052.5%
    15.3%
    -39.1%
    Weakening
    ReturnsROIC
    6.3%
    3.3%
    1.6%
    -1.6%
    -2.1%
    -133.3%
    -3.2%
    -199.1%
    -3.6%
    -321.7%
    -2.8%
    -72.4%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$1.78B$1.98B$2.18B$2.17B$2.80B$3.23B$3.30B$3.56B$3.74B
    Short-Term Investments
    Total Current Assets$13.79B$13.46B$13.01B$12.57B$12.05B$12.48B$12.55B$13.95B$13.71B
    Net PP&E$6.87B$6.95B$6.86B$6.48B$6.16B$6.15B$4.95B$4.42B$4.33B
    Goodwill$24.92B$24.85B$20.62B$17.63B$17.18B$17.18B$16.00B$16.00B$15.82B
    Intangibles$14.01B$11.23B$8.92B$7.47B$6.27B$5.39B$4.42B$3.78B$3.61B
    Total Assets$60.68B$57.47B$50.64B$47.67B$44.01B$43.48B$39.33B$40.75B$40.04B
    LiabilitiesTotal Current Liabilities$14.32B$13.67B$13.16B$11.03B$11.47B$12.25B$12.80B$13.46B$13.53B
    Short-Term Debt$2.22B$2.35B$3.19B$1.43B$2.11B$1.67B$1.78B$1.82B$2.61B
    Long-Term Debt
    Long-Term Leases$435.00M$479.00M$416.00M$349.00M$320.00M$296.00M$288.00M$280.00M
    Total Liabilities$44.89B$42.41B$39.58B$36.42B$35.41B$35.35B$33.61B$32.83B$31.81B
    EquityCommon Stock & APIC$56.00M$56.00M$57.00M$57.00M$57.00M$57.00M$58.00M$58.00M$59.00M
    Retained Earnings-$5.96B-$6.96B-$10.95B-$10.53B-$12.97B-$13.53B-$15.17B-$13.76B-$13.39B
    Total Equity$14.71B$13.97B$10.03B$10.28B$7.80B$7.51B$5.37B$7.91B$8.23B
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$2.45B$748.00M$1.22B$798.00M$1.59B$1.37B$1.25B$1.65B$1.71B
    Cash from Investing$1.87B$1.35B$863.00M$1.52B$656.00M$968.00M$792.00M$737.00M$765.00M
    Cash from Financing-$3.35B-$1.93B-$1.89B-$2.17B-$1.49B-$1.91B-$1.79B-$2.15B-$394.00M
    SummaryCapital Expenditure-$651.00M-$525.00M-$578.00M-$562.00M-$548.00M-$526.00M-$498.00M-$501.00M-$542.00M
    Free Cash Flow$1.79B$223.00M$638.00M$236.00M$1.04B$842.00M$749.00M$1.15B$1.17B
    FCF Margin9.8%1.3%3.8%1.5%7.0%5.3%4.5%6.7%8.3%